Sherry Mou

1.1k total citations
28 papers, 860 citations indexed

About

Sherry Mou is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Sherry Mou has authored 28 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Genetics and 7 papers in Oncology. Recurrent topics in Sherry Mou's work include Bacillus and Francisella bacterial research (10 papers), Yersinia bacterium, plague, ectoparasites research (9 papers) and Burkholderia infections and melioidosis (6 papers). Sherry Mou is often cited by papers focused on Bacillus and Francisella bacterial research (10 papers), Yersinia bacterium, plague, ectoparasites research (9 papers) and Burkholderia infections and melioidosis (6 papers). Sherry Mou collaborates with scholars based in United States, Czechia and Austria. Sherry Mou's co-authors include Diana Linnekin, Patricia L. Worsham, T A Gregorio, Kristin L. Komschlies, Jeffrey Subleski, Lisa Geiselhart, Dan L. Longo, DL Longo, D K Ferris and Virginia C. Broudy and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Sherry Mou

26 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sherry Mou United States 14 400 350 162 162 140 28 860
A. M. Lázaro United States 25 592 1.5× 728 2.1× 47 0.3× 169 1.0× 116 0.8× 72 1.8k
Rick de Waard Netherlands 9 492 1.2× 311 0.9× 213 1.3× 66 0.4× 41 0.3× 9 1.1k
Mani Larijani Canada 22 656 1.6× 575 1.6× 139 0.9× 125 0.8× 46 0.3× 48 1.2k
Pamela Mukhopadhyay Australia 19 198 0.5× 641 1.8× 196 1.2× 118 0.7× 130 0.9× 32 970
Lissa R. Herron United States 12 932 2.3× 333 1.0× 160 1.0× 132 0.8× 49 0.3× 17 1.5k
Robert Wadley Australia 10 982 2.5× 276 0.8× 250 1.5× 49 0.3× 158 1.1× 14 1.3k
Glennelle C. Washington United States 11 303 0.8× 163 0.5× 132 0.8× 56 0.3× 93 0.7× 11 688
Karen Duus United States 22 545 1.4× 284 0.8× 229 1.4× 98 0.6× 53 0.4× 34 1.3k
Ian Mockridge United Kingdom 10 998 2.5× 537 1.5× 308 1.9× 298 1.8× 50 0.4× 12 1.6k
L d'Auriol France 21 370 0.9× 805 2.3× 143 0.9× 526 3.2× 350 2.5× 34 1.9k

Countries citing papers authored by Sherry Mou

Since Specialization
Citations

This map shows the geographic impact of Sherry Mou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Mou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Mou more than expected).

Fields of papers citing papers by Sherry Mou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherry Mou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Mou. The network helps show where Sherry Mou may publish in the future.

Co-authorship network of co-authors of Sherry Mou

This figure shows the co-authorship network connecting the top 25 collaborators of Sherry Mou. A scholar is included among the top collaborators of Sherry Mou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry Mou. Sherry Mou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meinig, J. Matthew, Robert P. Edwards, Christopher P. Klimko, et al.. (2025). Implementation of a post-exposure tularemia treatment model for pneumonic challenged Fischer rats. Microbial Pathogenesis. 208. 107981–107981.
3.
Klimko, Christopher P., Jennifer L. Shoe, Sherry Mou, et al.. (2023). The rLVS Δ capB / iglABC vaccine provides potent protection in Fischer rats against inhalational tularemia caused by various virulent Francisella tularensis strains. Human Vaccines & Immunotherapeutics. 19(3). 2277083–2277083. 1 indexed citations
5.
Okaro, Udoka, Sherry Mou, Janice A. Williams, et al.. (2022). A type IVB pilin influences twitching motility and in vitro adhesion to epithelial cells in Burkholderia pseudomallei. Microbiology. 168(3). 10 indexed citations
8.
Strašková, Adéla, et al.. (2015). Francisella tularensistype B ΔdsbAmutant protects against type A strain and induces strong inflammatory cytokine and Th1-like antibody responsein vivo. Pathogens and Disease. 73(8). ftv058–ftv058. 11 indexed citations
9.
Bozue, Joel A., Christopher K. Cote, Taylor Chance, et al.. (2014). A Yersinia pestis tat Mutant Is Attenuated in Bubonic and Small-Aerosol Pneumonic Challenge Models of Infection but Not As Attenuated by Intranasal Challenge. PLoS ONE. 9(8). e104524–e104524. 11 indexed citations
10.
Mou, Sherry, Christopher K. Cote, & Patricia L. Worsham. (2012). Cytotoxic Necrotizing Factor Is an Effective Immunogen in a Yersinia pseudotuberculosis Aerosol Mouse Model. Advances in experimental medicine and biology. 954. 179–181. 2 indexed citations
11.
Worsham, Patricia L., Sherry Mou, Christopher K. Cote, & David Fritz. (2012). Virulence of Yersinia pseudotuberculosis in Aerosol Models. Advances in experimental medicine and biology. 954. 217–222. 2 indexed citations
12.
Eppinger, Mark, Lyndsay Radnedge, Gary L. Andersen, et al.. (2012). Novel Plasmids and Resistance Phenotypes in Yersinia pestis: Unique Plasmid Inventory of Strain Java 9 Mediates High Levels of Arsenic Resistance. PLoS ONE. 7(3). e32911–e32911. 22 indexed citations
13.
Bozue, Joel A., Sherry Mou, Krishna Moody, et al.. (2011). The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis. Microbial Pathogenesis. 50(6). 314–321. 33 indexed citations
14.
Geiselhart, Lisa, et al.. (2001). IL-7 Administration Alters the CD4:CD8 Ratio, Increases T Cell Numbers, and Increases T Cell Function in the Absence of Activation. The Journal of Immunology. 166(5). 3019–3027. 117 indexed citations
15.
Linnekin, Diana, Sherry Mou, Sarah R. Weiler, et al.. (1997). Stem Cell Factor, the JAK-STAT Pathway and Signal Transduction. Leukemia & lymphoma. 27(5-6). 439–444. 41 indexed citations
16.
Linnekin, Diana, et al.. (1997). Lyn Associates with the Juxtamembrane Region of c-Kit and Is Activated by Stem Cell Factor in Hematopoietic Cell Lines and Normal Progenitor Cells. Journal of Biological Chemistry. 272(43). 27450–27455. 146 indexed citations
17.
Mou, Sherry, et al.. (1997). Stat1 associates with c-kit and is activated in response to stem cell factor. Biochemical Journal. 327(1). 73–80. 93 indexed citations
18.
Linnekin, Diana, Sarah R. Weiler, Sherry Mou, et al.. (1996). JAK2 Is Constitutively Associated with c-Kit and Is Phosphorylated in Response to Stem Cell Factor. Acta Haematologica. 95(3-4). 224–228. 22 indexed citations
19.
Linnekin, Diana, Jonathan R. Keller, Douglas K. Ferris, et al.. (1995). Stem Cell Factor Induces Phosphorylation of a 200 kDa Protein which Associates with c-kit. Growth Factors. 12(1). 57–67. 8 indexed citations
20.
Linnekin, Diana, Sherry Mou, Peter A. Greer, Dan L. Longo, & Douglas K. Ferris. (1995). Phosphorylation of a Fes-related Protein in Response to Granulocyte-Macrophage Colony Stimulating Factor. Journal of Biological Chemistry. 270(9). 4950–4954. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026